Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Allergy Clin Immunol Pract ; 12(8): 2135-2143, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38729302

RESUMO

BACKGROUND: Anaphylaxis has been increasing in recent years, with common triggers in infants being milk and eggs. Currently, the mainstay of treatment for milk and/or egg allergy is strict avoidance. Recently, new therapies have emerged including stepwise introduction of allergens via a ladder approach. The suitability of infants for the ladders is debated. OBJECTIVE: This study aims to focus on the use of food ladders in children with anaphylaxis to egg or milk. METHODS: Retrospective review of pediatric patients diagnosed with immunoglobulin E-mediated milk and/or egg allergy between 2011 and 2021. Inclusion and exclusion criteria were applied. Anaphylaxis was defined as per the World Allergy Organization-amended criteria 2020. Data analysis utilized SPSS Version 28. RESULTS: We reviewed 1,552 patient charts, and excluded 1,094, leaving a total sample size of 458. Seventy infants had anaphylaxis at diagnosis (milk n = 36; egg n = 34). A range of 77.8% to 85.2% of infants with anaphylaxis successfully completed the ladder, 88.9% to 92.9% without anaphylaxis were successful. Children who successfully completed the ladder did so at similar rates. A range of 20.6% to 50% children presenting with anaphylaxis at diagnosis experienced allergic symptoms during treatment, compared with 17.3% to 40.7% without anaphylaxis. Reactions were mild, mostly cutaneous and not requiring medical attention. Patients experiencing allergic symptoms while on the ladder were less likely to successfully complete treatment. CONCLUSIONS: Milk and egg ladders are a safe and effective way of inducing tolerance in infants, including those with a history of anaphylaxis at diagnosis. There are no obvious predictors for who will experience allergic reactions while on the ladder; however, these children are less likely to complete the ladder, so parents should be educated in management of mild allergic reactions at home.


Assuntos
Anafilaxia , Hipersensibilidade a Ovo , Hipersensibilidade a Leite , Humanos , Anafilaxia/diagnóstico , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/terapia , Hipersensibilidade a Leite/dietoterapia , Hipersensibilidade a Leite/imunologia , Hipersensibilidade a Leite/terapia , Hipersensibilidade a Leite/diagnóstico , Estudos Retrospectivos , Lactente , Feminino , Masculino , Pré-Escolar , Imunoglobulina E/sangue , Alérgenos/imunologia , Criança , Animais , Leite/efeitos adversos , Leite/imunologia , Ovos/efeitos adversos
2.
Ir J Med Sci ; 188(1): 5-12, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29633161

RESUMO

BACKGROUND/AIMS: The financial crisis that enveloped Europe in 2009 created financial pressure for governments and required a number of countries to obtain a financial bailout from the IMF. The purpose of this paper is to examine the effect of the financial crisis on public health expenditure in bailout countries and if bailouts shift the burden of paying for healthcare from the state onto individuals. METHODS: Quantitative health expenditure data were collected from the WHO and OECD for the period 2004-2015 and evaluated using a comparison of means Welch's t test. RESULTS: The majority of bailout countries recorded a decrease in public health expenditure as a percentage of total government expenditure, with Ireland recording the largest decrease with government health expenditure as a percentage of total government expenditure, falling by 22% (P < .01). In addition, the results also suggest that the burden of paying for healthcare shifted from the state onto individuals in three countries, namely Hungary, Ireland and Portugal, where public health expenditure declined and private expenditure increased significantly. CONCLUSIONS: The ramifications of shifting the burden of paying for healthcare from the state onto individuals at this point remain unclear with further research required to identify the long-term consequences for healthcare.


Assuntos
Atenção à Saúde/economia , Apoio Financeiro , Gastos em Saúde/estatística & dados numéricos , Saúde Pública/economia , Recessão Econômica , Europa (Continente) , Gastos em Saúde/tendências , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA